Safety and efficacy of the Mynx Control vascular closure device in peripheral arterial procedures: A prospective study

1. Jiang, J, Zou, J, Ma, H, et al. Network Meta-analysis of Randomized Trials on the Safety of Vascular Closure Devices for Femoral Arterial Puncture Site Haemostasis. Scientific Rep 2015; 5(1): 13761. 10.1038/srep13761
Google Scholar | Crossref | Medline2. Helde, S, Gewalt, S, Ibrahim, T, et al. Gender specific analysis of the randomized ISAR-CLOSURE trial: the comparison of vascular closure devices versus manual compression after femoral artery puncture. J Am Coll Cardiol 2014; 6411(B): B245. 10.1161/CIRCINTERVENTIONS.117.006074
Google Scholar | Crossref3. Barbetta, I, van den Berg, J. Access and Hemostasis: Femoral and Popliteal Approaches and Closure Devices-Why, What, When, and How? Semin Interv Radiol 2014; 31(04): 353–360. 10.1055/s-0034-1393972
Google Scholar | Crossref | Medline4. Pruski, MJ, Blachut, AM, Konkolewska, M, et al. MynxGrip for Closure of Antegrade Puncture After Peripheral Interventions With Same-Day Discharge. Vasc Endovascular Surg 2017; 51(2): 67–71. 10.1177/1538574416689424
Google Scholar | SAGE Journals | ISI5. Krishnasamy, VP, Hagar, MJ, Scher, DJ, et al. Vascular Closure Devices: Technical Tips, Complications, and Management. Tech Vasc Interv Radiol 2015; 18(2): 100–112. 10.1053/j.tvir.2015.04.008
Google Scholar | Crossref | Medline6. Chaudhuri, A, York, A, Dey, R. Percutaneous vascular closure using an anchored collagen plug provides effective haemostasis following both antegrade and retrograde femoral arterial punctures. Eur J Vasc Endovascular Surg 2014; 48(2): 220–225. 10.1016/j.ejvs.2014.04.017
Google Scholar | Crossref | Medline7. Chiu, AHY, Coles, SR, Tibballs, J, et al. The StarClose Vascular Closure Device in Antegrade and Retrograde Punctures: A Single-Center Experience. J Endovascular Ther 2010; 17(1): 46–50. 10.1583/09-2873.1
Google Scholar | SAGE Journals | ISI8. Sekhar, A, Sutton, BS, Raheja, P, et al. Femoral arterial closure using ProGlide is more efficacious and cost-effective when ambulating early following cardiac catheterization. IJC Heart & Vasculature 2016; 13: 6–13. 10.1016/j.ijcha.2016.09.002
Google Scholar | Crossref | Medline9. Miranda, J, Pallister, Z, Hansraj, N, et al. 2021. Duplex-Ultrasound Assisted Mynx Closure of Superficial Femoral Artery Antegrade Access Following Lower-Extremity Endovascular Intervention. Journal of Critical Limb ischemia, 1(2).
Google Scholar10. Filippiadis, DK, Binkert, C, Pellerin, O, et al. Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System. CardioVascular Interv Radiol 2017; 40(8): 1141–1146. 10.1007/s00270-017-1703-4
Google Scholar | Crossref | Medline11. Sheth, RA, Walker, TG, Saad, WE, et al. Quality Improvement Guidelines for Vascular Access and Closure Device Use. J Vasc Interv Radiol 2014; 25(1): 73–84. 10.1016/j.jvir.2013.08.011
Google Scholar | Crossref | Medline12. Modi, S, Gadvi, R, Babu, S. Initial experience with Angioseal™: Safety and efficacy of the endovascular closure device. Indian Journal Radiology Imaging 2013; 23(2): 134, 8. 10.4103/0971-3026.116566
Google Scholar | Crossref | Medline13. Baker, NC, Escarcega, RO, Lipinski, MJ, et al. Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis. J Interv Cardiol 2016; 29(1): 108–112. 10.1111/joic.12264
Google Scholar | Crossref | Medline14. Veasey, RA, Large, JK, Silberbauer, J, et al. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital - the SCOAST study. Int J Clin Pract 2008; 62(6): 912–918. 10.1111/j.1742-1241.2008.01761.x
Google Scholar | Crossref | Medline15. Lucatelli, P, Fanelli, F, Cannavale, A, et al. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures. J Cardiovascular Surgery 2017; 58: 80–86. 10.23736/S0021-9509.16.07654-0
Google Scholar | Crossref | Medline16. Spiliopoulos, S, Katsanos, K, Karnabatidis, D, et al. Safety and Efficacy of the StarClose Vascular Closure Device in More Than 1000 Consecutive Peripheral Angioplasty Procedures. J Endovascular Ther 2011; 18(3): 435–443. 10.1583/10-3277.1.
Google Scholar | SAGE Journals | ISI17. Klein-Wiele, O, Baliota, M, Kara, K, et al. Safety and efficacy of clip-based vs. suture mediated vascular closure for femoral access hemostasis: A prospective randomized single center study comparing the StarClose and the ProGlide device. Catheterization Cardiovasc Interventions 2017; 91(3): 402–407. 10.1002/ccd.27116
Google Scholar | Crossref | Medline18. Biancari, F, Romppanen, H, Savontaus, M, et al. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. Int J Cardiol 2018; 263: 29–31. 10.1016/j.ijcard.2018.04.065.
Google Scholar | Crossref | Medline19. Berti, S, Bedogni, F, Giordano, A, et al. Efficacy and Safety of ProGlide Versus Prostar XL Vascular Closure Devices in Transcatheter Aortic Valve Replacement: The RISPEVA Registry. J Am Heart Assoc 2020; 9(21); e018042. 10.1161/JAHA.120.018042
Google Scholar | Crossref | Medline20. Dauerman, HL, Applegate, RJ, Cohen, DJ. Vascular Closure Devices. J Am Coll Cardiol 2007; 50(17): 1617–1626. 10.1016/j.jvs.2018.05.01
Google Scholar | Crossref | Medline | ISI21. Fields, JD, Liu, KC, Lee, DS, et al. Femoral artery complications associated with the Mynx closure device. Am J Neuroradiology 2010; 31(9): 1737–1740. 10.3174/ajnr.A2153
Google Scholar | Crossref | Medline | ISI22. Saad, NEA, Saad, WEA, Davies, MG, et al. Pseudoaneurysms and the Role of Minimally Invasive Techniques in Their Management. RadioGraphics 2005; 25(suppl_1): S173–S189. 10.1148/rg.25si055503
Google Scholar | Crossref | Medline23. Hackl, G, Gary, T, Belaj, K, et al. Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients. Diagn Interv Radiol 2014; 20(5): 426–431. 10.5152/dir.2014.14002
Google Scholar | Crossref | Medline | ISI24. Gutzeit, A, van Schie, B, Schoch, E, et al. Feasibility and Safety of Vascular Closure Devices in an Antegrade Approach to Either the Common Femoral Artery or the Superficial Femoral Artery. CardioVascular Interv Radiol 2012; 35(5): 1036–1040. 10.1007/s00270-012-0454-5
Google Scholar | Crossref | Medline | ISI25. Ratnam, LA, Raja, J, Munneke, GJ, et al. Prospective nonrandomized trial of manual compression and Angio-seal and StarClose arterial closure devices in common femoral punctures. CardioVascular Interv Radiol 2007; 30(2): 182–188. 10.1007/s00270-006-0226-1
Google Scholar | Crossref | Medline26. Lupattelli, T, Tannouri, F, Garaci, FG, et al. Efficacy and Safety of Antegrade Common Femoral Artery Access Closure Using the Angio-Seal Device: Experience With 1889 Interventions for Critical Limb Ischemia in Diabetic Patients. J Endovascular Ther 2010; 17(3): 366–375. 10.1583/09-2960.1
Google Scholar | SAGE Journals | ISI27. Thurley, PD, O’Neill, R, Habib, S, et al. Re: Looby et al.: “Efficacy and Safety of the Angioseal Vascular Closure Device Post Antegrade Puncture”. CardioVascular Interv Radiol 2008; 31(6): 1255–1256. 10.1007/s00270-008-9411-8
Google Scholar | Crossref | Medline28. Hwang, JH, Park, SW, Yang, WY, et al. Safety and efficacy of Mynx vascular closure device for the closure of common femoral artery access after ipsilateral stent placement. The J Vasc Access 2020: 112972982096694. 10.1177/1129729820966946
Google Scholar | SAGE Journals

Comments (0)

No login
gif